Literature DB >> 4127044

Adenosine deaminase deficiency in a child with severe combined immunodeficiency.

B B Knudsen, J Dissing.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4127044     DOI: 10.1111/j.1399-0004.1973.tb01929.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  8 in total

1.  Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis.

Authors:  M C Pike; N M Kredich; R Snyderman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Adenosine deaminase activity in livers of congenitally athymic nude mice.

Authors:  S I Deutsch; T J Romano; N K Ghosh; R P Cox
Journal:  Experientia       Date:  1974-11-15

3.  Uridine monophosphate kinase: A new genetic polymorphism with possible clinical implications.

Authors:  E R Giblett; J E Anderson; S H Chen; Y S Teng; F Cohen
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

4.  Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977.

Authors:  A B Kenny; W H Hitzig
Journal:  Eur J Pediatr       Date:  1979-06-28       Impact factor: 3.183

5.  Conversion of human erythrocyte-adenosine deaminase activity to different tissue-specific isozymes. Evidence for a common catalytic unit.

Authors:  R Hirschhorn
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

6.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

7.  Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis.

Authors:  F Hirata; S Toyoshima; J Axelrod; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

Review 8.  Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Gemma Navarro; Irene Reyes-Resina
Journal:  Cells       Date:  2021-10-21       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.